GENICON: Keep Growing or Sell the Company? Harvard Case Solution & Analysis

GENICON, a private medical device manufacturer, founded over 15 years ago. Ahead of changes to U.S. healthcare system, the industry started to consolidate and the CEO of the company received various acquisition offers. The CEO has to make a vital decision that whether he should sell the company and put millions in his pocket or he should continue along with his investors to expand the business. However, the company owned a significant debt, thus the CEO does not want to take any more to invest in the capital. Would it be better for him to sell the existing business completely and start a new venture? Or sell to take the help from the acquirer to grow this business? Or sell just a plant or some part of the company, which would reduce the autonomy and authority? However, the CEO is aware of the potential, but it requires him to make a quick and accurate decision. Gary Haberland has the affiliation with President and founder of GENICON while the author, Allen H. Kupetz, has the affiliation with Rollins College.

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.